Cargando…

ODP259 Evaluating the Efficacy and Safety of Long-Acting GLP-1 Receptor Agonist in T1DM Patients

INTRODUCTION: GLP-1 receptor agonist is a medication class that mimics the endogenous incretin hormone GLP-1. Short-acting GLP-1 agents were studied as adjunct therapies in type 1 diabetes (T1DM) but not approved due to concern of increased diabetic ketoacidosis (DKA) risk. Long-acting GLP-1 medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohandas, Deene, Gao, Catherine, Calma, Jamie, Basina, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628966/
http://dx.doi.org/10.1210/jendso/bvac150.706

Ejemplares similares